Biogen Inc

Call
Website
500 Kendall St
Cambridge, MA 02142
+1 (781) 464-2000
https://www.biogen.com

Biogen Inc, located in Cambridge, MA, is a biotechnology company dedicated to discovering and developing transformative medicines for neurological and neurodegenerative diseases, including Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis. The company emphasizes its commitment to innovation, health equity, and corporate responsibility, striving to make a meaningful impact on patients' lives through science and research.

With a focus on collaboration and a diverse workforce, Biogen fosters an inclusive culture that encourages employees to tackle complex challenges in healthcare. The company is also actively engaged in community initiatives and sustainability efforts, reflecting its mission to not only advance medical science but also support broader societal goals.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Sanofi Genzyme

In operation since 1981, Genzyme Corporation is one of the leading biotechnology companies in the world. The company employs a staff of more than 12,000 people and manages over 85 locations in nearly 40 countries. It focuses on the areas of hematologic oncology, biosurgery, transplant, genetic diseases, and cardiometabolic and renal. Genzyme Corporation offers Fabrazyme, which is a solution for intravenous infusion. The company also provides Fabrazyme, Renagel, Renvela and Hectorol. It offers solutions for the medical and patient communities. In addition, Genzyme Corporation offers Synvisc, which is a viscosupplementation treatment for relieving knee pain associated with osteoarthritis. The company provides Sepra, which is a line of hyaluronic acid-based products.
Business services, nec, nec, Drugs acting on the respiratory system, Blood derivatives

Orbital Therapeutics

Orbital Therapeutics, based in Cambridge, MA, is dedicated to advancing RNA medicines aimed at expanding access to innovative therapies for patients with various diseases. Their cutting-edge platform integrates RNA discovery and design, focusing on immune reprogramming to help restore health by delivering precise molecular instructions directly to immune cells. The company emphasizes a culture of collaboration and has assembled a team experienced in transitioning medicines from concept to clinical application. Through their comprehensive RNA platform, Orbital Therapeutics seeks to engineer durable therapies with the flexibility needed to effectively modulate disease outcomes. Generated from the website
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Cambridge›Biogen Inc

Partial Data by Infogroup (c) 2025. All rights reserved.